NAMS fundamentals
An in-depth look to NewAmsterdam Pharma Company N.V. operating, investing, and financing activities
NAMS free cash flow for Q1 24 is -54.99 M USD. For 2023, NAMS free cash flow was -141.24 M USD and operating cash flow was -141.22 M USD.
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
TTM